Caradon Therapeutics
Encinitas, US · Founded 2023 · Delaware corporation
Biotech
Founders & leadership
BL
Brian Laurence JohnsonExecutive
Reported raises · per SEC filings
Form D private placements$559.3K disclosed across 1 round · 2026
▶$559.3KraisedFeb 2026 · 7 investors · BiotechnologyRule 506(b)
▶$559.3KraisedFeb 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian Laurence JohnsonExecutive Officer, Director
- Offering amount
- $900K
- Amount sold
- $559.3K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Caradon Therapeutics raised?
- Caradon Therapeutics has disclosed $559.3K raised across 1 round.
- Where is Caradon Therapeutics headquartered?
- Caradon Therapeutics is headquartered in Encinitas, US.